Mirabegron

Products Mirabegron is commercially available in the form of sustained-release film-coated tablets (Betmiga, USA: Myrbetriq). It was approved in the US and EU in 2012 and in many countries in 2014. Mirabegron was the first agent from the beta3 agonist group to be approved for the treatment of irritable bladder. It was originally intended to … Mirabegron

Suxamethonium Chloride

Products Suxamethonium chloride is commercially available as a solution for injection (lysthenone, succinoline). It was introduced in the 1950s and has been approved in many countries since 1954. Suxamethonium chloride is also known as succinylcholine or succinylcholine chloride, especially in English. In jargon, it is also called Suxi or Sux. Structure and properties Suxamethonium chloride … Suxamethonium Chloride

Lofexidine

Products Lofexidine was approved in the United States in 2018 in film-coated tablet form (Lucemyra). In the United Kingdom, the agent was approved for the treatment of opioid withdrawal back in the early 1990s (UK: BritLofex). Structure and properties Lofexidine (C11H12Cl2N2O, Mr = 259.1 g/mol) is present in the drug as lofexidine hydrochloride, a white … Lofexidine

Eluxadoline

Products Eluxadoline was approved in the form of film-coated tablets in the US in 2015, in the EU in 2016, and in many countries in 2018 (US: Viberzi, EU, CH: Truberzi). Structure and properties Eluxadoline (C32H35N5O5, Mr = 569.7 g/mol) Effects Eluxadoline (ATC A07DA06) has antidiarrheal and analgesic properties. It is an agonist at μ-opioid … Eluxadoline

Capsaicin Cream

Products Capsaicin cream at 0.025% or 0.075% (also 0.1%) is not registered as a finished drug in many countries, unlike other countries. It is produced as an extemporaneous preparation in pharmacies. The specialized trade can also order them from specialized service providers. On the other hand, patches containing the active ingredient (Qutenza) are approved as … Capsaicin Cream

Capsaicin

Products Capsaicin is commercially available in many countries as creams and patches, among other products. Capsaicin cream at 0.025% and 0.075% is not commercially available as a finished drug product. It is produced as a magisterial formulation in pharmacies. See also under the article capsaicin cream. Structure and properties Capsaicin (C18H27NO3, Mr = 305.4 g/mol) … Capsaicin

Hydromorphone

Products Hydromorphone is commercially available as sustained-release tablets, sustained-release capsules, capsules, solution for injection, solution for infusion, and drops (e.g., Palladon, Jurnista, Hydromorphoni HCl Streuli). It has been approved in many countries since 1996. Structure and properties Hydromorphone (C17H19NO3, Mr = 285.3 g/mol) is a semisynthetic, hydrogenated and oxidized morphine derivative. It is present in … Hydromorphone

Cannabidiol

Products In many countries, there are currently no medicines approved that contain only cannabidiol. However, the active ingredient is a component of the cannabis oral spray Sativex, which is registered as a drug for MS treatment in many countries and also contains THC. The oral solution Epidiolex or Epidyolex was approved as a drug in … Cannabidiol

Cannabidiol Hemp

Products Hemp with a high content of cannabidiol and a low total content of tetrahydrocannabinol (less than 1%) can be legally sold in many countries since 2016 and is available from specialized suppliers and web stores. Cannabidiol hemp is approved as a tobacco substitute product and not yet as a medicine. Neither cannabidiol nor cannabidiol … Cannabidiol Hemp

Nalmefene

Products Nalmefene is commercially available in the form of film-coated tablets (Selincro). It was registered in many countries in 2014. Structure and properties Nalmefene (C21H25NO3, Mr = 339.4 g/mol) is structurally closely related to naltrexone, from which it is derived. In the drug product, it is present as nalmefene hydrochloride and dihydrate, a white crystalline … Nalmefene